Genomic characterization of a new phage BUCT541 against Klebsiella pneumoniae K1-ST23 and efficacy assessment in mouse and Galleria mellonella larvae

Over the past decades, the spread of multi-drug-resistant Klebsiella pneumoniae (MDR-KP) is becoming a new threat and new effective therapies against this pathogen are needed. Bacteriophage (phage) therapy is considered to be a promising alternative treatment for MDR-KP infections compared with anti...

Descripción completa

Detalles Bibliográficos
Autores principales: Pu, Mingfang, Li, Yahao, Han, Pengjun, Lin, Wei, Geng, Ronghua, Qu, Fen, An, Xiaoping, Song, Lihua, Tong, Yigang, Zhang, Shuyan, Cai, Zhen, Fan, Huahao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523250/
https://www.ncbi.nlm.nih.gov/pubmed/36187954
http://dx.doi.org/10.3389/fmicb.2022.950737

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523250/
https://www.ncbi.nlm.nih.gov/pubmed/36187954
http://dx.doi.org/10.3389/fmicb.2022.950737

Ejemplares similares